Tenon Medical (US:TNON) — Company Overview, News & Financial Data

Tenon Medical logo
TNONTenon Medical
Trade TNON now
Tenon Medical primary media

About Tenon Medical

Tenon Medical (NASDAQ:TNON) specializes in the development and commercialization of innovative medical devices designed to address the needs of patients undergoing sacroiliac joint fusion surgery. The company is committed to improving patient outcomes and reducing recovery times with their cutting-edge technology. Their flagship project focuses on a minimally invasive solution that aims to advance the standards of care for individuals suffering from sacroiliac joint dysfunction, a common source of lower back pain. Tenon Medical's objective is to lead the way in creating reliable, patient-friendly treatments that offer a quicker return to normal activities and less post-operative discomfort.

What is TNON known for?

Snapshot

Public US
Ownership
2012
Year founded
22
Employees
Los Gatos, United States
Head office
Loading Map...

Operations

All Locations
United States

Products and/or services of Tenon Medical

  • Developed the Catamaran(TM) Single-Procedure Sacroiliac Joint Fusion System for minimally invasive treatment of sacroiliac joint dysfunction.
  • Advances in sacroiliac joint diagnostic tools to enhance the accuracy and efficiency of diagnosing joint dysfunction.
  • Creation of patient-specific surgical planning technology to improve outcomes in sacroiliac joint fusion surgeries.
  • Innovative post-operative care solutions aimed at reducing recovery time and improving patient comfort following sacroiliac joint fusion.
  • Educational programs and resources for healthcare professionals on the diagnosis and treatment of sacroiliac joint dysfunction.
  • Collaborative research projects with medical institutions to study the long-term outcomes of sacroiliac joint fusion procedures.

Tenon Medical executive team

  • Mr. Steven M. FosterCEO, President & Director
  • Mr. Richard GinnFounder, CTO, COO & Director
  • Mr. Kevin WilliamsonChief Financial Officer
  • Mr. Richard M. FerrariFounder & Executive Chairman
  • Mr. Steve MoscaretGeneral Manager of Marketing & Sales Operation
  • Nathaniel A. GraweyChief Commercial Officer
  • Mr. Wyatt GiestChief Innovation Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.